Veradermics shareholder plans sale of 135K shares

MANE has filed a notice of proposed sale of 135,000 shares of common stock under Form 144.

Rhea-AI Filing Summary

MANE has filed a notice of proposed sale of 135,000 shares of common stock under Form 144. The filing lists an aggregate market value of $15,022,800 for these shares and shows 41,780,136 shares outstanding as of 08/17/2026 on the NYSE.

The 135,000 shares consist of 3,452 shares acquired through a stock option and 131,548 founder shares, both originally acquired from the issuer. No sales of these securities are reported during the past three months.

Key Figures

Shares to be sold: 135,000 shares Aggregate market value: $15,022,800 Shares outstanding: 41,780,136 shares +3 more

6 metrics

Shares to be sold 135,000 shares Common stock proposed to be sold under Form 144

Aggregate market value $15,022,800 Market value of 135,000 shares proposed for sale

Shares outstanding 41,780,136 shares Common shares outstanding as of 08/17/2026

Stock option shares 3,452 shares Portion of proposed sale originating from a stock option

Founder shares 131,548 shares Portion of proposed sale consisting of founder shares

Form 144 date 08/17/2026 As-of date associated with the Form 144 and securities data

Key Terms

Form 144, aggregate market value, Founder Shares, Stock Option

4 terms

Form 144 regulatory

"144: Filer Information 144: Issuer Information 144: Securities Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

aggregate market value financial

"Common | J.P. Morgan Securities LLC ... | 135000 | 15022800 | 41780136"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

Founder Shares financial

"Common | 03/24/2020 | Founder Shares | Issuer"

Founder shares are the ownership stakes given to the people who start a company, often with extra voting power or protections compared with ordinary shares. For investors, they matter because founders’ control and incentives influence decisions about strategy, hiring, and whether the company sells or stays independent — like a family that keeps majority voting rights in a household decision. High founder ownership can mean stable leadership but also a risk that outside shareholders have less influence.

Stock Option financial

"Common | 08/17/2026 | Stock Option | Issuer"

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does MANE’s Form 144 filing disclose about planned share sales?

The filing indicates a proposed sale of 135,000 MANE common shares under Form 144. These shares have an aggregate market value of $15,022,800 and are part of the company’s 41,780,136 shares outstanding as of August 17, 2026.

How many MANE shares are covered by this Form 144 and what is their value?

The Form 144 covers 135,000 MANE common shares with an aggregate market value of $15,022,800. The filing also notes that MANE had 41,780,136 shares outstanding as of August 17, 2026 on the NYSE.

What types of MANE securities are included in the 135,000 shares on Form 144?

The 135,000 MANE shares consist of 3,452 shares from a stock option and 131,548 founder shares. Both categories are listed as acquired from the issuer, and together they comprise the total shares proposed for sale.

When were the MANE stock option and founder shares originally acquired?

The stock option-related MANE shares are tied to a date of 08/17/2026, while the founder shares reference an acquisition date of 03/24/2020. These dates identify when each type of security was originally granted or acquired from the issuer.

Has the MANE insider sold any of these securities in the past three months?

No recent sales are reported. The Form 144 section for securities sold during the past 3 months shows no disclosed transactions, indicating no reported sales of the listed MANE securities in that period.

On which exchange are MANE shares referenced in this Form 144 listed?

The shares referenced in the Form 144 are listed on the NYSE. The filing notes the MANE common stock as traded on this exchange in connection with the 135,000 shares proposed for sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/17/2026 - 05:31 PM Accepted by SEC EDGAR 08/17/2026 - 05:30 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002107415
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	VERADERMICS INC
SEC File Number	001-43097
Address of Issuer	470 James Street New Haven CONNECTICUT 06513
Phone	228-372-3376
Name of Person for Whose Account the Securities are To Be Sold	Reid Alexander Waldman
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	CEO

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	J.P. Morgan Securities LLC 270 Park Avenue 10th Floor New York NY 10017	135000	15022800	41780136	08/17/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/17/2026	Stock Option	Issuer			3452	08/17/2026	Cash
Common	03/24/2020	Founder Shares	Issuer			131548	03/24/2020	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/17/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Reid Alexander Waldman.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)